Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

926
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
926
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

908
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[How does the surgical society (DGAV) support the continuing medical training in general and visceral surgery?]

Chirurgie (Heidelberg, Germany)·2023
Same author

[Impact of the COVID pandemic on treatment of bariatric patients in Germany-An analysis of the national StuDoQ/MBE register].

Chirurgie (Heidelberg, Germany)·2023
Same author

[Statement of the surgical working group upper gastrointestinal tract (CAOGI) and the quality committee of the German Society for General and Visceral Surgery (DGAV) on the modified minimum caseload requirements for esophagus resection].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2021
Same author

[Advanced training of general and visceral surgeons in life-saving emergency surgery : Results of a survey among participants of a surgery course].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020
Same author

MTL, a composite measure for objectively profiling hospitals on surgical performance in colorectal cancer surgery.

International journal of colorectal disease·2019
Same author

[German Society for General and Visceral Surgery (DGAV) risk calculator of interventions for colorectal cancer : Presentation of a surgical algorithm on patient participation and quality assurance].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2019

Related Experiment Video

Updated: May 6, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.7K

[Refractory inflammatory bowel disease: surgical challenges].

H J Buhr1, A J Kroesen

  • 1Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie e.V., Haus der Bundespressekonferenz, Schiffbauerdamm 40, 10117, Berlin, Deutschland, hbuhr@dgav.de.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 31, 2013
PubMed
Summary

For Crohn's disease surgery, stopping immunosuppressants and biologics may improve outcomes. For ulcerative colitis, these drugs are a risk factor for infections, necessitating careful management strategies.

More Related Videos

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

2.1K
Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
04:14

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

Published on: September 22, 2023

1.1K

Related Experiment Videos

Last Updated: May 6, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.7K
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

2.1K
Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
04:14

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

Published on: September 22, 2023

1.1K

Area of Science:

  • Gastroenterology and Surgery
  • Immunopharmacology

Context:

  • Inflammatory bowel disease (IBD) management has evolved, with most patients now on immunosuppressants or biologics before surgery.
  • The impact of these agents on surgical outcomes in IBD remains inconsistently reported.

Purpose:

  • To analyze the risks associated with immunosuppressant and biologic agents in IBD surgery.
  • To differentiate the impact of these therapies on Crohn's disease versus ulcerative colitis surgical outcomes.

Summary:

  • Monotherapy with immunosuppressants or biologics appears safe for Crohn's disease surgery.
  • Biologics and immunosuppressants as combination therapy are increasingly recognized as infection risk factors in ulcerative colitis surgery.
  • Preoperative optimization strategies include nutritional support, corticosteroid reduction, drug cessation, and stoma creation for Crohn's disease.
  • A three-stage restorative proctocolectomy is preferred for high-risk ulcerative colitis patients.

Impact:

  • Findings guide risk stratification and perioperative management for IBD patients undergoing surgery.
  • Highlights the need for individualized treatment plans based on IBD subtype and medication regimen.
  • Informs clinical decision-making regarding the temporary cessation of immunosuppressants and biologics before surgery to mitigate infectious complications.